+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Parkinsonism and Related Disorders 17(10): 730-736

Polymorphisms in SNCA, MAPT and LRRK2 genes have recently been confirmed as risk factors for Parkinson's disease (PD), although with small individual attributable risk. Here we investigated the association of PD with interactions between variants of these genes. As part of a previous study of PD susceptibility genes 119 SNCA, MAPT, and LRRK2 haplotype tagging single nucleotide polymorphisms (SNPs) and two variable number tandem repeats (VNTRs) were genotyped in 1098 PD cases from the upper Midwest, USA and 1098 matched controls. Twenty-six of these SNPs were selected for SNP-SNP (or SNP-VNTR or VNTR-VNTR) interaction analysis (256 interaction pairs). Case-control analyses were performed to study association of pairwise SNP interactions with PD susceptibility. Out of the 256 interaction pairs investigated, 10 had uncorrected p-values <0.05. These represented six SNCA-LRRK2 pairs, three SNCA-MAPT pairs, and one MAPT-LRRK2 pair. However, none of these pairwise interactions were significant after correction for multiple testing. Secondary analyses in strata defined by type of control (sibling or unrelated), sex, or age at onset of the case also did not reveal any significant interactions after accounting for multiple testing. This study provides no statistically significant evidence of gene-gene interaction effects for the three confirmed genetic susceptibility loci for PD. However, this does not exclude the possibility that other genomic loci or environmental risk factors interact with these genes.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052678464

Download citation: RISBibTeXText

PMID: 21816655

DOI: 10.1016/j.parkreldis.2011.07.001

Related references

Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients. Neuroscience Letters 706: 140-145, 2019

Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. Movement Disorders 26(5): 819-823, 2011

SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia. Parkinsonism and Related Disorders 19(11): 1064-1065, 2013

The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population. European Journal of Neurology 21(11): E91-E92, 2014

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiology of Aging 35(1): 266.E5, 2014

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurology 71(11): 1405-1412, 2014

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Annals of Neurology 69(5): 778-792, 2011

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population. Parkinsonism and Related Disorders 18(3): 257-262, 2012

Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population. Eneurologicalsci 1(1): 3-6, 2015

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population. Parkinson's Disease 2016: 3474751, 2016

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Neuroscience Letters 635: 67-70, 2016

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. Movement Disorders 33(12): 1857-1870, 2018

A BACwards glance at neurodegeneration: molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice. Biochemical Society Transactions 39(4): 862-867, 2011

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Human Mutation 31(7): 763-780, 2010

Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. European Journal of Neurology 14(1): 7, 2007